Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries I-MAB - American Depositary Shares (NQ: IMAB ) 0.8800 -0.0200 (-2.22%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 366,287 Open 0.9000 Bid (Size) 0.8700 (1) Ask (Size) 0.9280 (13) Prev. Close 0.9000 Today's Range 0.8512 - 0.9280 52wk Range 0.8512 - 2.536 Shares Outstanding 185,613,662 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Wednesday's Intraday Session October 02, 2024 Via Benzinga Week In Review: Zenas Raises $259 Million In IPO September 28, 2024 It was a quiet week for biotech news in the Chinese market. Here is a brief overview of the notable events that occurred during this time. Zenas BioPharma staged a rare US biopharma IPO worth $259... Via Talk Markets Topics Initial Public Offering Exposures Securities Market Performance YTD -60.89% -60.89% 1 Month -7.46% -7.46% 3 Month -23.48% -23.48% 6 Month -47.31% -47.31% 1 Year -51.91% -51.91% More News Read More Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million June 08, 2024 Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga (IMAB) - Analyzing I-MAB's Short Interest May 07, 2024 Via Benzinga Looking Into I-MAB's Recent Short Interest February 07, 2024 Via Benzinga Expert Ratings for I-MAB September 25, 2023 Via Benzinga Where I-MAB Stands With Analysts September 05, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 04, 2024 Via Benzinga NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday March 18, 2024 Via Benzinga Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million February 11, 2024 Via Talk Markets 12 Health Care Stocks Moving In Friday's After-Market Session December 15, 2023 Via Benzinga Analyst Ratings for I-MAB August 18, 2023 Via Benzinga 5 Analysts Have This to Say About I-MAB June 05, 2023 Via Benzinga I-Mab Reveals Promising Results in Phase 1b/2 Study for Advanced Non-Small Cell Lung Cancer Treatment May 26, 2023 Via Benzinga Week In Review: Two China Biopharmas Announce Billion Dollar Deals October 14, 2023 Via Talk Markets Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq September 30, 2023 Via Talk Markets Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 28, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday September 28, 2023 Via InvestorPlace Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal September 02, 2023 Via Talk Markets 7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole August 25, 2023 Via InvestorPlace Why Is TRACON Pharma (TCON) Stock Down 51% Today? April 25, 2023 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 25, 2023 Via InvestorPlace Last Day Of Q1 March 31, 2023 Via Benzinga ImmuneOnco Banks On Cutting-edge Cancer Drugs To Attract IPO Cash March 31, 2023 Via Benzinga Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
